ArticleCellular & molecular immunology2023

Engineering immunosuppressive drug-resistant armored (IDRA) SARS-CoV-2 T cells for cell therapy.

Qi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.